B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 769-776

  Bain, Christine ^a   Merrouche, Y ^a   Puisieux, Isabelle ^a   Duc, Adeline ^a   Colombo, Mario Paolo ^b   Favrot, Marie ^a  

^a CENTRE LÉON BÉRARD   (France)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIGENS, CD80; CARCINOMA, RENAL CELL; CELL DIVISION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029958612     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<769::AID-IJC4>3.0.CO;2-P     Document Type: Article

References (31)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R.M. and FINKE, J.H., T cells infiltrating renal-cell carcinoma display a poor proliferate response even though they can produce interleukin 2 and express interleukin-2 receptors. Cancer Res., 53, 1380-1387 (1993).
2. AZUMA, M., CAYABYAB, M., PHILLIPS, J.H. and LANIER, L.L., Requirements for CD28-dependent T-cell-mediated cytotoxicity. J. Immunol., 150, 2091-2101 (1993).
3. BASKAR, S., OSTRAND-ROSENGERG, S., NABAVI, N., NADLER, L.M., FREEMAN, G.J. and GLIMCHER, L.H., Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major-histocompatibility-complex-class-II molecules. Proc. nat. Acad. Sci. (Wash.), 90, 5687-5690 (1993).
4. BOUSSIOTIS, V.A., FREEMAN, G.J., GRAY, G., GRIBBEN, J. and NADLER, L.M., B7 but not intercellular-adhesipn-molecule-1 co-stimulation prevents the induction of human alloantigen-specific tolerance. J. exp. Med., 178, 1753-1763 (1993).
5. CHEN, L., ASHE, S., BRADY, W.A., HELLSTRÖM, I., HELLSTRÖM, K.E., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Co-stimulation of anti-tumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4, Cell, 71, 1093-1102 (1992).
6. CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTRÖM, I. and HELLSTRÖM, K.E., tumor immunogenicity determines the effect of B7 co-stimulation on T-cell-mediated tumor immunity. J. exp. Med., 179, 523-532 (1994).
7. COMBARET, V., FAVROT, M.C., KREMENS, B., PHILIP, I., BAILLY, C., FONTANIERE, B., ZUCKER, J.M., BERNARD, J.L. and PHILIP, T., Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation. Brit. J. Cancer, 59, 844-847 (1989).
8. DÖHRING, C., ANGMAN, L., SPAGNOLI, G. and LANZAVECCHIA, A., T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer, 57, 754-759 (1994).
9. EBERT, E.C., ROBERTS, A.I., O'CONNELL, S.M., ROBERTSON, F.M. and NAGASE, H., Characterization of an immunosuppressive factor derived from colon-cancer cells. J. Immunol., 138, 2161-2168 (1987).
10. FAVROT, M.C., COMBARET, V., NEGRIER, S., PHILIP, I., THIESSE, P., FREIDEL, C., BIJMAN, J.T., FRANKS, C.R., MERCATELLO, A. and PHILIP, T., Functional and immunophenotypic modifications induced by IL2 did not predict response to therapy in patients with renal-cell carcinoma. J. biol. Response Modif., 9, 167-177 (1990).
11. + T-cell line. J. Immunother., 11, 1-11 (1992).
12. GAJEWSKI, T.F., RENAULD, J.C., VAN PEL, A. and BOON, T., Costimulation with B7-1, IL6, and IL12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro. J. Immunol., 154, 5637-5648 (1995).
13. + cytotoxic T lymphocytes in the absence of exogenous help. J. exp. Med., 177, 1791-1796 (1993).
14. HARDING, F.A., MCARTHUR, J.G., GROSS, J.A., RAULET, D.H. and ALLISON, J.P., CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.), 356, 607-609 (1992).
15. HOUGHTON, A.N., Cancer antigens: immune recognition of self and altered self. J. exp. Med., 180, 1-4 (1994).
16. KATZ, S.E. and SCHAPIRA, H.E., Spontaneous regression of genitourinary cancer - an update. J. Urol., 128, 1-4 (1982).
17. KOO, A.S., TSO, C.L., SHIMABUKURO, T., PEYRET, C., DEKERNION, J.B. and BELLDEGRUN, A., Autolpgous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal-cell carcinoma. J. Immunother., 10, 347-354 (1991).
18. LANIER, L.L., O'FALLON, S., SOMOZA, C., PHILLIPS, J.H., LINSLEY, P.S., OKUMURA, K., ITO, D. and AZUMA, M., CD80 (B7) and CD86 (B7.2) provide similar co-stimulatory signals for T-cell proliferation, cytokine production and generation of CTL. J. Immunol., 1, 97-105 (1995).
19. LIU, Y., JONES, B., ARUFFO, A., SULLIVAN, K.M., LINSLEY, P.S. and JANEWAY, C.A., Heat-stable antigen is a co-stimulatory molecule for CD4 T-cell growth. J. exp. Med., 175, 437-445 (1992).
20. MIESCHER, S., WHITESIDE, T.L., CARREL, S. and VON FLIEDNER, V., Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136, 1899-1907 (1986).
21. NABAVI, N., FREEMAN, G.J., GAULT, A., GODFREY, D., NADLER, L.M. and GLIMCHER, L.H., Signalling through the MHC-class-II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (Lond.), 360, 266-268 (1992).
22. PUISIEUX, I., EVEN, J., PANNETIER, C., JOTEREAU, F., FAVROT, M. and KOURILSKY, P., Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol., 153, 2807-2818 (1994).
23. PUISIEUX, I., BAIN, C., MERROUCHE, Y., MALACHER, P., KOURILSKY, P., EVEN, J. and FAVROT, M., Restriction of the T cell repertoire in tumor infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions. Int. J. Cancer, 66, 201-208 (1996).
24. RAMARATHINAM, L., CASTLE, M., WU, Y. and LIU, Y., T-cell costimulation by B7/BB1 induces CD8 T-cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of anti-tumor T cells. J. exp. Med., 179, 1205-1214 (1994).
25. ROSENBERG, S.A., LOTZE, M.T., MUUL, L.M., CHANG, A.E., AVIS, F.P., LEITMAN, S., LINEMAN, W.M., ROBERTSON, C.N., LEE, R.E., RUBIN, J.T., SEIPP, C.A., SIMPSON, C.G. and WHITE, D.E., A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. New Engl. J. Med., 316, 879-897 (1987).
26. SCHENDEL, D.J., GANSBACHER, B., OBERNEDER, R., KRIEGMAIR, M., HOFSTETTER, A., RIETHMÜLLER, G. and SEGURADO, O.G., Tumor-specific lysis of human renal-cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151, 4209-4220 (1993).
27. SCHWARTZ, R.H., A cell-culture model for T-lymphocyte clonal anergy. Science, 248, 1349-1356 (1990).
28. SENSI, M., SALVI, S., CASTELLI, C., MACALLI, C., MAZZOCCHI, A., MORTARINI, R., NICOLINI, G., HERLYN, M., PARMIANI, G. and ANICHINI, A., T-cell-receptor (TCR) structure of autologous melanoma-reactive cytotoxic-T-lymphocyte (CTL) clones: tumor-infiltrating lymphocytes over-express in vivo the TCR β-chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. exp. Med., 178, 1231-1246 (1993).
29. SULÉ-SUSO, J., ARIENTI, F., MELANI, C., COLOMBO, M.P. and PARMIANI, G., A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes. Europ. J. Immunol., 25, 2737-2742 (1995).
30. + T cells by B7-transfected melanoma cells. Science, 259, 368-370 (1993).
31. WANG, Q., REDOVAN, C., TUBBS, R., OLENCKI, T., KLEIN, E., KUDOH, S., FINKE, J. and BUKOWSKI, R.M., Selective cytokine gene expression in renal-cell-carcinoma tumor cells and tumor-infiltrating lymphocytes. Int. J. Cancer, 61, 780-785 (1995).